• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELEKTA LTD AGILITY; ACCELERATOR, LINEAR, MEDICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELEKTA LTD AGILITY; ACCELERATOR, LINEAR, MEDICAL Back to Search Results
Device Problem Computer Software Problem (1112)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 02/23/2015
Event Type  malfunction  
Manufacturer Narrative
The manufacturer's device analysis results: for this issue to occur: the abnormal termination has to occur during the intersegment after mlc/bm control system loads the next shape and before the linac control system loads its next segment which clears the dose.I.E.The condition which contributes to the hazard is that the incremented control point still has dose associated with it.The dose display will show the actual dose delivered.A finish field is created which uses the incorrect control point for the dose delivered, resulting in a finish field which will underdose.The user delivers the finish field, underdosing the patient without realising that there is anything wrong.Mosaiq records that the total prescribed dose was delivered: the linac dose counter will show the actual dose delivered for the finish field.The following warning is in the integrity 3.1 instructions for use - clinical mode manual, which if followed, would detect this issue: warning 5.2; when an abnormal termination of a field occurs, you must look at the beam mu display and record the value.You must do a check, in the r&v system, that the remaining mu to be delivered in the finish field that results is correct before you continue.If you ignore this warning, it can cause clinical mistreatment.This issue has been fixed in integrity 3.2; during delivery, if the accumulated segment dose for a beam is more than a set value mu greater than the beam dose, the system shall terminate the beam and set the accumulated segment dose to the beam dose.Remedial action/corrective action/preventive action / field safety corrective action this issue has been resolved in integrity 3.2 which has been released as a mandatory modification kit to the field.Time schedule for the implementation of the identified actions: this modification kit has already been released.Further investigations: none.Is the manufacturer aware of similar incidents with this type of medical device with a similar root cause? yes - 2 (b)(6).The following has been updated: email address updated.The following has been updated: establishment name.The following has been updated: manufacturing site/address has been updated.Resubmitting form 3500a due to an administrative error.This has now been corrected so that only "initial" has been checked and not both "initial" and "follow-up" as requested by fda medwatch program department.Correction ticked.The method code and result code that were used in the previous report submitted on 03/31/2015 are obsolete.(b)(4).
 
Event Description
The customer reported an integrity mu mismatch between mosaiq and the linac dose counter.Two patients were affected by this issue.The first received an underdose of 211 mu for a treatment segment (out of the 2200 mu that was prescribed).The situation on the second patient remains unknown at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGILITY
Type of Device
ACCELERATOR, LINEAR, MEDICAL
Manufacturer (Section D)
ELEKTA LTD
linac house
fleming way
crawley, RH10 9RR
UK  RH10 9RR
Manufacturer (Section G)
ELEKTA LTD
linac house
fleming way
crawley, RH10 9RR
UK   RH10 9RR
Manufacturer Contact
pms
linac house
fleming way
crawley, west sussex RH10 -9RR
UK   RH10 9RR
MDR Report Key4646190
MDR Text Key240443030
Report Number9617016-2015-00004
Device Sequence Number1
Product Code IYE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123808
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Remedial Action Modification/Adjustment
Type of Report Initial
Report Date 05/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/02/2015
Initial Date FDA Received03/31/2015
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-